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Abstract 
 
The folding of proteins was investigated by using helical polypeptides attached to 
gold or magnetite nanoparticle surfaces.  
Depending on type and loading of the polypeptide on the surface of gold 
nanoparticles, pH, temperature, presence of different ions in the solution, and influence of 
different mechanical factors, conformational changes in the polypeptide occurred. The 
aggregation of the gold nanoparticles related to the folding of the polypeptide caused 
shifts in color of the solutions from red to blue that were measured by UV-Vis 
spectrometry.  
Different ligands were attached on the surface of magnetite nanoparticles. The 
resulting structures induced modifications in the characteristics of the superparamagnetic 
resonance (SRP) spectra of magnetite nanoparticles.  Lineshape parameters related to the 
anisotropy and crystal structure revealed ligand-dependent and temperature-dependent 
SPR spectra. The attachment of ligands leads further to the possibility of attaching model 
polypeptides on the magnetite nanoparticles surface for studying protein folding.  
 
 
iv
  
Introduction 
 
21st century science deals extensively with the highly emerging field of 
nanomaterials. Nanomaterials are structures with dimensions in the mesoscopic range 
(between 1 and 100 nm). Physics and electronics are building nanostructures by using 
conventional top-down techniques like lithography and etching [1]. By self-assembly and 
building up of blocks, nature serves a great model for nanotechnology. Thus, today’s 
chemistry and materials science are using bottom-up approaches, the biggest problems in 
the building process being the induction of molecular self-organization and the 
functionalization of the resulting nanostructures [2]. 
Lately, the combination of nanomaterials and biological molecules proved to be 
attractive for new applications in electronics, genomics, and biomedical and bioanalytical 
areas [3]. The linkage is currently done by modifying the biological molecules with a 
chemical group that is reactive towards the nanomaterial surface [4]. Biological molecules 
can be either absorbed on the surface of the nanomaterial [5] or they can form electrostatic 
interactions with the oppositely charged nanostructures [6]. Still, the most desired binding 
is through chemical bonds [7]. Extensive studies have been done on functionalized gold 
and magnetic nanoparticles [8]. Bioconjugation of Au nanoparticles with oligonucleotide 
via thiol group [1] or immobilization of different drugs on the surface of magnetite 
nanoparticles [1] were reported. DNA-modified Au nanoparticles have been used for the 
detection of DNA-sequences [9]. Au nanoparticles proved also to be effective carriers for 
the delivery of DNA into the cell [1]. Cd/Se nanoparticles coated with biological ligands 
specific for certain cellular structures were used in fluorescence labeling of cells [10]. 
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 Drugs attached to the surface of magnetic nanoparticles were directed with magnetic 
fields to the target tissues [11]. Magnetic nanoparticles incorporated into malignant cells 
and excited with alternating magnetic fields were also used in order to increase local 
temperature that induced hyperthermia [12].  
However, the attaching of proteins to the surface of metallic nanoparticles is 
currently a real challenge. Proteins are either hydrophobic or hydrophilic, they have 
either positive or negative charge and their structures are complicated comparing to DNA 
and RNA. Thus, although a specific interaction between the proteins and nanoparticles is 
desired, in practice, the nonspecific binding often occurs [13]. While much effort has gone 
into the development of a specific proteins-nanoparticles binding for sensors and 
actuators applications, only a few studies focused on the conformational changes that 
occur when a protein encounters a surface [14]. The final goals of these studies are to 
detect and to understand the proteins conformation and to measure the nanomaterial 
surface coverage [14]. 
 By folding into specific three-dimensional shapes, proteins are able to perform 
their biological functions. The particular amino-acid sequence that gives the primary 
structure of a protein determines how the protein will fold into its native conformation. 
The folding process depends on the characteristics of the proteins environment (solvent, 
concentration of salts, temperature) and is mediated by electrostatic interactions 
(hydrogen bonds, van der Waals interactions) between amino acid R groups [15]. These 
interactions establish the formation of the alpha helices and beta sheets (secondary 
structure). Tertiary and quaternary structure formation involves covalent bonding 
between cysteine residues, directing the assembly of the subunits that are already folded. 
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Folding is a spontaneous process. The phenomenon is driven by van der Waals 
forces and entropic contributions to the Gibbs free energy. Moving the hydrophobic 
amino acids of the protein inwards and the hydrophilic ones outwards produces an 
increase in entropy necessary for overcoming the energy barrier that allows the protein to 
achieve its native folding [16]. The time scale of the process depends mostly on the 
protein; the slowest folding require minutes, primarily due to steric hindrances, while 
typical folding needs only milliseconds [17].  
The current interest in the folding process comes from the fact that incorrectly 
folded proteins are responsible for prion related diseases such as Creutzfeldt-Jacob 
disease and Bovine spongiform encephalopathy (mad cow disease), as well as amyloid 
related diseases such as Alzheimer disease. It is believed that the aggregation of 
misfolded proteins into insoluble plaques are the cause of these diseases [18]. 
Currently, protein folding is studied by expensive and complicated techniques like 
computational prediction of the conformation, circular dichroism, IR spectroscopy, X-ray 
crystallography and NMR. All these methods investigate protein structure in solution or 
on a two-dimensional surface; folding studies using proteins attached to three-
dimensional surfaces (like nanoparticles) are still in an initial phase. A series of questions 
rise from these studies: are the proteins denatured or active, folded or unfolded, or how 
the proteins adsorption on the surface of the nanoparticles be controlled? 
The hypothesis of our study is that the folding of a protein attached to a three-
dimensional surface is basically identical to the one that occurs on a two-dimensional 
surface. This is the reason why we assumed that model polypeptides attached to either 
gold or magnetite nanoparticles surface can be used to investigate the folding and 
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unfolding of proteins. Because more than 50% of the natural proteins have helical 
structures and helices are the first structures that form in the folding process [16], we 
believe that a relatively short, helical polypeptide can serve as a simplified model for the 
study of a protein folding. Our resulting bio-nanostructures were investigated by 
transmission electron microscopy (TEM). A UV-Vis spectrophotometer was used to 
characterize the polypeptide-Au nanoparticles samples. An EPR spectrometer was used 
to characterize the ligands-magnetite nanoparticles.      
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Chapter 1 
Studies of Protein Folding using Gold Nanoparticles 
 
1.1 Introduction 
Gold colloids are stable dispersions of Au nanoparticles in a liquid phase. The 
stability of the colloid is given by the structure of the Au nanoparticles: elemental gold 
core surrounded by two charged layers (a negative inner layer formed by AuCl- ions, 
called zeta potential, and a positive outer layer formed by H+ ions) [19]. 
  
 
 
 
 
 
 
 
Figure 1.1: Gold nanoparticle surrounded by charged layers 
 
 
Thiol groups bind covalently to the Au nanoparticles surfaces. Thus, for the 
bioconjugation of Au nanoparticles with proteins, it is easy to just add thiol-modified 
proteins to a solution of Au nanoparticles [4]. Thiol modified-proteins have cysteine 
residues accessible for interphase coupling and incorporated into their structure by 
chemical or genetic engineering methods [1].  
The subsequent problems like the flocculation of colloidal gold by the protein and 
the failure of the protein to be absorbed by colloidal gold, can be solved through the 
application of concentration and pH variable adsorption isotherms [20,21].  
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Zare and collaborators proved that conformational changes in proteins can be 
studied using cytochrome C protein covalently attached to the surface of gold 
nanoparticles via a thiol bond [22]. The binding of the proteins to the surface of gold 
nanoparticles and the aggregation of the coated nanoparticles changed the color of the 
investigated solutions. The result was assumed to be a surface plasmon effect. Surface 
plasmon resonance is a quantum optical-electrical phenomenon that is produced by the 
interaction of light with a metal surface. Under certain conditions (only at a specific 
resonance wavelength), the energy carried by photons of light is transferred to packets of 
electrons (called plasmons) on a metal’s surface [23] and the energy that is lost can be 
detected in the form of ultraviolet or visible radiation [24]. Although the change in color of 
the solutions in this study was due to the aggregation of the nanoparticles and not to the 
conformational changes in the protein, it is believed that these two phenomena are related 
[22]. 
 
1.2 Experimental section 
 1.2.1 Materials and equipment 
Au nanoparticles with diameters of 5 nm, and respectively 10 nm, produced by 
modified tannic acid / citrate method that makes use of the tetrachloric acid (HAuCl4) 
reduction [25], were purchased from Sigma-Aldrich. FmocAla, FmocLys and FmocCys 
amino acids were used for the synthesis of the model polypeptide. Organic solvents and 
the other chemicals of AR grade were used as received. 
The model polypeptide was synthesized by using Fmoc procedure on an APEX 
peptide synthesizer [26]. HPLC Beckam-Coulter System Gold with a semiprep column at 
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220 nm was used to purify the resulting polypeptide. TEM images were taken on a JEOL 
Model 2010 electron microscope operated at 120 kV. A UV-Vis spectrophotometer was 
used to characterize the samples with respect to their wavelength and absorbance. The 
wavelength range used was between 500 and 700 nm since previous experiments showed 
that gold nanoparticles absorb at around 515 nm while polypeptide coated gold 
nanoparticles absorb at around 570 nm. 
1.2.2 Preparation of the polypeptide 
For studying the folding process, a helical polypeptide having the following 
sequence AcAAAAKAAAAKAAAAKCNH2 (called 3K16) was synthesized based on 
Fmoc method [26]. The polypeptide chain was constructed on an insoluble solid Wang 
resin using dimethyl formamide (DMF) as a solvent. Piperdine diluted in DMF was used 
in order to remove the protective Fmoc group of the amino acids. The coupling step, in 
which the amide bond is formed, used HBTU (2-(1-benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate) and HoBt (1-Hydroxybenzotriazole) in DMF 
(0.5 M) as coupling reagents. The polypeptide product was cleaved from the resin with a 
mixture of trifluoroacetic acid (TFA), ethane dithiol, distilled water and 
triisopropylsylane (TIS) in a proportion of 94/2.5/2.5/1% v/v. The purification of the 
crude polypeptide based on size and polarity was done by reverse phase liquid 
chromatography using HPLC with a semiprep column with packing material composed of 
silica particles. Typical water/acetonitrile HPLC solvents (99.9% HPLC grade water; 
0.1% trifluoro acetic acid and 99.9% HPLC grade acetonitrile; 0.1% trifluoroacetic acid) 
and different methods [27] optimized to obtain better resolution of the peaks and shorter 
elution time were used for the purification of the resulting peptide.  
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In the figure below, the HPLC spectrum of the 3K16 polypeptide at 220 nm shows the 
peak produced by the polypeptide bond at a retention time of 16.417 minutes. The mass 
of the polypeptide was also confirmed by mass spectrometry at LSU Health Sciences 
Center. 
 
 
 
 
 
 
 
 
Figure 1.2:  HPLC spectrum of 3K16 polypeptide 
 
1.2.3 Preparation of polypeptide-Au nanoparticles bioconjugates 
3K16 polypeptide is monomeric in solution and it has a temperature dependent 
helical content. To allow the binding to the surface of the gold nanoparticles via a thiol 
bond, a cysteine amino acid was incorporated at the C terminus of the polypeptide. The 
amino-acids sequence of 3K16 polypeptide was modified by attachment of an acetyl 
group at the N terminus (acetylation) and of a NH3 group at the C terminus (amidation). 
Acetylation and amidation minimize unfavorable dipole-electrostatic interactions that 
would disrupt the helical folding of the polypeptide.  
Starting with a concentrated 5*1015 molecules/µL stock 3K16 solution (0.83 mM), 
samples with ratios 6000:1, 1500:1, 750:1 and 600:1 polypeptide to Au nanoparticles (10 
nm and respectively 5 nm) were prepared and their pH was measured as being 5.5 similar 
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to the gold colloid solution [25]. The resulting polypeptide-Au nanoparticles solutions 
were successively heated in a heat block 10 min at a temperature of 95oC, cooled in ice 
10 minutes and sonicated in a sonicator bath 1 minute. After each step the color of the 
solutions was visually observed, and the wavelength and the absorbance were measured 
by using a UV-Vis spectrophotometer.  
 
1.3 Results and discussion 
1.3.1 Characterization of polypeptide-Au nanoparticles bioconjugates using UV-
Vis spectrophotometry 
Depending on the loading of the polypeptide on the surface of gold nanoparticles, 
pH, temperature, or mechanical factors like sonication, particles aggregation was 
observed in the solutions. The wavelength and the absorbance were measured for these 
polypeptide-Au nanoparticles bioconjugates solutions before and after the appearance of 
the aggregation phenomenon, respectively before and after the sonication. The very broad 
peaks of UV-Vis spectrum obtained for each solution showed that aggregation of the 
nanoparticles occurred.  Certain values for the maximum wavelength (λ) and the 
maximum absorbance (A) for the polypeptide-10 nm Au nanoparticles bioconjugates 
were measured initially; after 45 minutes and respectively after 2:30 hours, when the 
aggregate was settled, the wavelength and the absorbance of the solutions were measured 
again. A small shift in λ and an appreciable decrease in absorbance were observed. In 
contrast, when the samples were sonicated 1 minute, the wavelengths were almost equal 
to the initial measured wavelengths while the absorbencies were higher. For 5 nm 
nanoparticles the observations were similar, the λ shifts and the differences in absorbance 
 
9  
  
as a function of time and after sonication, being very small. Reproducing the procedure 
and measuring again the wavelength and the absorbance verified all these results. The 
values of wavelength and absorbance for 10 and 5 nm at ratios 600:1, 750:1 and 1500:1 
polypeptide to nanoparticles are shown in the table below. 
3K16/10 
nm Au 
Solution + 
aggregate 
Solution 
(after 45 min 
settling) 
Solution 
(after 2:30 h 
settling) 
Solution 
(after 1 min 
sonication) 
ratio λ(nm) A λ(nm) A λ(nm) A λ(nm) A 
600:1 576 0.346 566 0.128 594 0.087 567 0.162 
750:1 580 0.552 580 0.379 583 0.309 582 0.395 
1500:1 567 0.229 570 0.079 600 0.057 567 0.113 
3K16/5 
nm Au 
Solution + 
aggregate 
Solution 
(after 45 min 
settling) 
Solution 
(after 2:30 h 
settling) 
Solution 
(after 1 min 
sonication) 
ratio λ(nm) A λ(nm) A λ(nm) A λ(nm) A 
600:1 535 0.856 535 0.853 534 0.841 533 0.787 
750:1 560 0.794 559 0.702 558 0.692 556 0.720 
1500:1 541 0.626 541 0.459 537 0.350 538 0.502 
 
Table 1.1: Wavelength and absorbance at different polypeptide to Au nanoparticles  
(10 nm and 5 nm) ratios as a function of time and sonication 
 
 
To test the influence of the temperature on the polypeptide-Au nanoparticles 
bioconjugates behavior in solutions, 600:1, 750:1, 1500:1 and 6000:1 3K16 polypeptide 
to Au nanoparticles (10 and 5 nm) ratios were investigated before and after thermic 
treatments. The samples were successively cooled in ice 1 hour, heated at 95oC 10 
minutes, cooled again 10 minutes, and finally, sonicated 1 minute. λ and A were 
measured after each step and their values are shown below.  
3K16/ 
10 nm 
Au 
initial after 1h in ice after 10min at 95oC 
after 10min in 
ice 
after 1min  
sonication 
ratio λ(nm) A λ(nm) A λ(nm) A λ(nm) A λ(nm) A 
600:1 519  0.808 519 0.798 517 0.801 518 0.784 518 0.727 
750:1 522 0.812 521 0.807 520 0.799 519 0.803 521 0.782 
1500:1 519  0.815 519 0.810 517 0.809 517 0.812 519 0.738 
3000:1 524  0.837 524 0.787 520 0.782 520 0.762 521 0.773 
4000:1 572  0.756 571 0.627 542 0.566 543 0.590 537 0.726 
6000:1 570 0.831 567 0.374 538 0.463 556 0.980 533 0.887 
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3K16/ 
5 nm 
Au 
initial after 1h in ice after 10min at 95oC 
after 10min in 
ice 
after 1min  
sonication 
ratio λ(nm) A λ(nm) A λ(nm) A λ(nm) A λ(nm) A 
600:1 516 0.751 516 0.747 515 0.771 514 0.769 515 0.745 
750:1 518 0.768 518 0.775 516 0.774 515 0.780 517 0.762 
1500:1 524  0.783 524 0.824 522 0.832 522 0.833 521 0.793 
6000:1 533 0.857 530 0.810 523 0.784 521 0.779 521 0.697 
 
Table 1.2: Wavelength and absorbance at different polypeptide to Au nanoparticles 
(10 nm and 5 nm) ratios as a function of temperature and sonication 
 
1.3.2 Characterization of polypeptide-Au nanoparticles bioconjugates using TEM 
TEM observation for two samples 3K16-10 nm Au nanoparticles with 6000 : 1 
ratio was performed. TEM images taken immediately after the sample preparation 
(mixing of 3K16 and 10 nm Au nanoparticles) revealed dispersed and aggregated Au 
nanoparticles, and organic material as well (Figure 1.3). The sample examined after 
overnight full saturation showed the existence of only aggregated nanoparticles (Figure 
1.4). 
 
                                                                 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: TEM images of 6000:1 ratio 3K16-10 nm Au nanoparticles  
sample immediately after preparation 
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Figure 1.4: TEM images of 6000:1 ratio 3K16-10 nm Au nanoparticles  
sample after overnight full saturation 
 
1.3.3 Discussion 
The change in color from red (in the Au nanoparticles stock solution) to pink (the 
initial color of the 3K16 polypeptide-Au nanoparticles solutions with 6000:1 and 1500:1 
ratios) and then to blue (in the same samples) is an indicator of the increase in size of the 
nanoparticles due to the bioconjugation that has been established between the 
nanoparticles surface and the polypeptide. This phenomenon is the result of the 
specificity of the thiol bond present in the cysteine terminal amino acid of the 3K16 
polypeptide for the Au surfaces. The change in color is also the result of the aggregation 
of coated nanoparticles that might be caused by the hydrophobic interactions established 
between the polypeptide molecules covalently bound on the surface of Au nanoparticles.  
The experiments also showed that temperature is an important factor in the 
process of polypeptide folding. At lower temperatures, the polypeptide is more folded and 
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the solutions are colored. At high temperatures, the polypeptide is less folded with lighter 
colors or even almost clears solutions. These color changes are quantified by the 
variations in measured wavelengths and absorbencies. In case of 3K16-10 nm Au 
nanoparticles with small ratios 600:1, 750:1, and 1500:1, the shifts in wavelengths and 
the differences in absorbencies are almost imperceptible. For the same nanoparticle 
diameter, 6000:1 ratio solution that was cooled in ice 1 hour, the increase in the 
wavelength indicates that the polypeptide is folded between λ = 556-567 nm. The data 
also showed that the polypeptide is unfolded when heated at 95 oC at λ = 538 nm and 
after 1 minute sonication at λ = 533 nm. Unfolding takes place due to the hydrophobic 
interactions that prevent proper helical conformation of the polypeptide [16]. The 3K16-10 
nm Au nanoparticles, 3000:1 ratio sample has a similar behavior as the smaller 
polypeptide to nanoparticles ratios (600:1, 750:1 and 1500:1), while the 4000:1 ratio 
behavior resembles to the 6000:1 one. The conformational changes in the polypeptide 
seem to be easily detected at ratios higher than 4000:1, 3K16 polypeptide to Au 
nanoparticles. In conclusion, variation in temperature affects the protein folding and 
unfolding, so it can affect the aggregation process of the polypeptide coated Au 
nanoparticles in solutions. 
For 3K16 polypeptide-5 nm Au nanoparticles samples, the similar values of λ and 
A from one experiment to another prove that the solutions color did not change as a 
function of temperature. Because there are around 5000 Au atoms on the surface of each 
5 nm Au nanoparticle (comparing with around 10000 Au atoms on the surface of each 10 
nm Au nanoparticle), it means that on a 5 nm Au nanoparticle surface there are more 
polypeptide molecules than Au atoms, so the interactions that establish between the 
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polypeptides on the surface of the nanoparticles seem to be responsible for the particular 
behavior of the 3K16-5 nm Au nanoparticles solutions. 
Sonication may also prevent the correct folding and as a result, the misfolding of 
the polypeptide may occur. Although because of the aggregation disappearance, our first 
hypothesis was that the polypeptide molecules are removed from the surface of the Au 
nanoparticles in the sonicated samples, the final observation of the aggregation after 24 
hours showed that the polypeptide is still on the surface of the nanoparticles. The 
disappearance of the aggregate and the color change from purple to clear are due to a 
conformational change in the polypeptide (maybe to the misfolding of the polypeptide 
that is responsible for the aggregation of the nanoparticles after the sonication of the 
solutions). 
At higher ratios 3K16-Au nanoparticles (1500:1 and 6000:1) for both 
nanoparticles diameters (5 and 10 nm), the hydrophobic interactions between the 
polypeptides are stronger than the electrostatic interactions that keep the nanoparticles 
dispersed in the solution and this is the reason why aggregation and change in color 
occur. At small ratios 3K16-Au nanoparticles (750:1 and 600:1) for both nanoparticles 
diameters (5 and 10 nm), the electrostatic forces are stronger than the hydrophobic ones 
and the solutions are stable. The experiments showed that the stability of the polypeptide-
Au nanoparticles solutions used for studying the folding process is governed by the 
polypeptide load on the surface of the Au nanoparticles, and also by the pH and 
temperature of the solutions. The results can be used in order to construct binding 
isotherms specific for the 3K16 helical model polypeptide. 
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1.4 Conclusions 
3K16 helical polypeptide is a proper model that mimics the behavior of a helical 
protein, so the method can be extended to the study of the protein folding. Although the 
quantified color changes in the solutions are the result of the aggregation of the 
polypeptide coated Au nanoparticles, the aggregation is directly related to the changes in 
the conformation of the attached polypeptide. Thus, Au nanoparticles can be used to 
create a colorimetric sensor for proteins conformational changes. 
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Chapter 2 
Studies of Protein Folding using Magnetite Nanoparticles 
 
2.1 Introduction 
Iron oxide nanoparticles are highly attractive to biological and medical 
applications due to their magnetic properties, chemical stability and biocompatibility. 
Although magnetite nanoparticles are known as magnetic contrast agents [28] and drug 
delivery vehicles [29], to our knowledge, magnetite nanoparticles have not been used 
before for the study of protein folding. 
Enhanced details of the magnetic characteristics of magnetite nanoparticles come 
from superparamagnetic (SPR) resonance studies. SPR is the resonant absorption of 
microwave radiation by superparamagnetic ions or molecules, with unpaired electron 
spins, in the presence of a static magnetic field [30]. SPR provides information about 
nanoparticles size, concentration, their magnetic anisotropy and coordination 
environment [31] and unlike electron paramagnetic resonance (EPR), it investigates 
systems containing many unpaired electrons. The SPR spectra of different 
superparamagnetic systems are characterized by the existence of a single line of a 
hyperlorentzian form close to the effective g-factor value geff = 2.0 [31]. Nanoparticles 
size-distribution and shape, their concentration, chemical environment, and not lastly, the 
temperature, are factors that influence the line-shape of the SPR spectrum. The 
temperature dependence of the linewidth is considered to be the consequence of the 
thermal fluctuations of the nanoparticles magnetic moments orientation with respect to 
the orientation of the applied magnetic field [32].  
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Three parameters are used to characterize SPR spectra: the polycrystalline 
effective g-factor, geff, the linewidth, ∆B, and the asymmetry ratio, A [33].  
 
 
 
 
 
 
 
 
 
Figure 2.1: Parameters of the SPR spectra 
 
 
The true g-factor is defined as: 
                                                                      , where h is the Planck’s constant, ν is the X-
band microwave frequency, β is the Bohr magneton, and Brfe is the applied field at which 
the maximum absorption occurs when the samples have no magnetic anisotropy [34]. For 
samples with magnetic anisotropy, an effective g-factor is defined as:                          
hg ν=
rfeBβ
                                                                      . g β= effeff B
hν
The relation between the true g-factor and effective g-factor gives information about the 
magnetic anisotropy and the size of the magnetic nanoparticles. 
The linewidth of the SPR spectrum, ∆B, is the distance between the maximum 
positive and negative peaks. The asymmetry ratio, A, is defined as the ratio between 
∆Bhigh and ∆Blow, where ∆Bhigh and ∆Blow are half linewidths at half maximum on the 
integrated spectrum [34] (Figure 2.1). 
 
17  
  
 By measuring the effective g-factor, geff, the linewidth, ∆B, and the asymmetry ratio, A, 
properties of the magnetic nanoparticles like magnetic anisotropy, nanoparticle size, 
composition and concentration, can be precisely quantified. The existence of the different 
ligands on the magnetite particle surface can also be detected. 
 
2.2 Experimental section 
2.2.1 Materials and equipment 
Magnetite nanoparticles with diameters of 10-12 nm in methanol were provided 
and used for our studies. 
Acids (citric acid), salts (sodium carbonate, sodium acetate) and proteins (bovine 
serum albumin, BSA) were purchased from Sigma-Aldrich and used as ligands attached 
to the surface of the magnetite nanoparticles. 
EPR experiments were performed on a Bruker EMX spectrometer equipped with a 
TE102 cavity, goniometer and variable temperature option. Samples of magnetite 
nanoparticles in different solvents, with or without ligands, were transferred to 100 µL 
quartz capillary tubes, and then flame-sealed. The X-band data 
(at a frequency of 9.8 GHz) were acquired at a power of 2-6 mW and a spectral width of 
8000 Gauss with centerfield at 4000 Gauss. The modulation amplitude used was 10 
Gauss, significantly less than the smallest linewidth. The time constant was 41 ms, the 
conversion time was 81.6 ms, and the frequency modulation was 100 kHz. For every 
experiment, the first-derivative of the absorption was monitored as a function of the 
applied field (B). 
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 At the zero-crossing point in the first-derivative spectrum, the derivative of the power is 
zero (dAbs/dB = 0) and defines the resonance field (Beff). The temperature dependence of 
the magnetic properties for the magnetite nanoparticles was studied from 100-370 K with 
increments of 10 K and accuracy of +/-0.1 K. 
2.2.2 Preparation of the magnetite nanoparticles 
Magnetite nanoparticles result from the hydrolysis of chelated alkoxide complexes 
of Fe2+ and Fe3+ in solutions of diethylene glycol (DEG) and N-methyl diethanol amine 
(NMDEA) and of diethylene glycol (DEG) and diethanol amine (DEA) at high 
temperature [35]. Magnetite, Fe3O4, has an inverse spinel crystal structure (Figure 2.2), 
FeO•Fe2O3, with face centered cubic unit cell that contains 56 atoms: 32 O2- anions, 16 
Fe3+ cations (half of them tetrahedrally coordinated and the other half octahedrally 
coordinated) and 8 Fe2+ cations (all of them octahedrally coordinated) [36]. 
 
 
 
 
 
 
 
Figure 2.2: Magnetite, Fe3O4, inverse spinel crystal structure FeO•Fe2O3 
 
The synthesis of the magnetite is problematic because magnetite readily oxidizes 
in air to maghemite γ-Fe2O3, which is the reason why argon or nitrogen atmosphere is 
commonly used. Two different magnetite nanoparticles samples with diameters of 10-12 
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nm (with DEG and NMDEA on the surface, and respectively with DEG and DEA on the 
surface) were synthesized. The resulting magnetite nanoparticles were stored and 
provided to us in methanol after extensive washing in order to remove the chelating 
agents. 
2.2.3 Preparation of the ligands-magnetite nanoparticles biocojugates 
The EPR measurements were made for magnetite nanoparticles either in methanol 
or in methanol solutions with ligands. The transfer of the nanoparticles into the methanol-
ligand solutions was accomplished first by isolating the magnetite nanoparticles with a 
strong magnet (5 Oe), washing them three times, and finally re-suspending them in the 
desired ligand-methanol solution. In cases when, under the influence of ligands, the 
nanoparticles precipitated, the solution was vortexed immediately prior to transfer into a 
quartz capillary tube. Dilutions (1:20, 1:40, 1:200, 1:1000) of magnetite in methanol, 
solutions of 9:1 magnetite nanoparticles to citric acid in methanol (0.25 mg/mL, 0.5 
mg/mL, 1 mg/mL, 1.25 mg/mL, 1.5 mg/mL) and solutions of Fe3O4 nanoparticles in 
methanol (1 mg/mL) and cosolutes like sodium carbonate, sodium acetate and 
respectively bovine serum albumin (BSA) were prepared and used in the EPR studies. 
 
2.3 Results and discussion 
In magnetite, half of the 16 Fe3+ cations are tetrahedrally coordinated and the 
other half octahedrally coordinated, while all 8 Fe2+ cations are octahedrally coordinated 
by oxygen [36]. The distribution of Fe3+ and Fe2+ ions in octrahedral and tedrahedral sites 
is illustrated in the figure below. 
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 Figure 2.3: Magnetic behavior of magnetite, Fe3O4,  
ferromagnetic and antiferromagnetic couplings 
 
The electron transfer from a high-spin Fe2+ to a neighboring Fe3+, in octahedral 
sites, known as double exchange, favors the ferromagnetic ordering of the magnetic 
moments. Superexchange leads to an antiferromagnetic alignment of the spins on the 
tetrahedral iron and limits the magnetic behavior of the particles to Fe3+ ↔ Fe2+ 
ferromagnetic coupling [37], which is detected by the EPR. Due to the electron migration 
between Fe3+ and Fe2+ ions, the real charge of the iron ions in magnetite is in fact, Fe2.5+. 
Thus, Fe3O4 is ferrimagnetic. 
2.3.1 Characterization of magnetite nanoparticles in methanol solutions using 
EPR spectroscopy 
EPR spectrum for the magnetite nanoparticles in methanol sample (20 mg/mL) 
was acquired and used for comparison with all the other acquired spectra (Figure 2.4). 
Inter-particle dipolar exchange was demonstrated by the calculated parameters that 
characterize the EPR spectra (Table 2.1).  
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Figure 2.4: EPR spectrum of magnetite nanoparticles 
 
sample Xmin Xmax ∆B Beff ∆Blow ∆Bhigh A geff 
Fe3O4 1982.36 4138.95 2156.59 2280.49 298.13 1858.46 6.23 3.1 
 
Table 2.1: Parameters of magnetite nanoparticles EPR spectrum 
 
 
Using magnetically dilute samples can minimize dipolar exchange effects. In 
order to find out the threshold concentration for which there is no spin-spin interactions 
between the nanoparticles, dilutions of magnetite samples in methanol were prepared. 
The EPR measurements are affected by variables like temperature and polarity [38]. Our 
experiments were done at room temperature but the difference in the spectra comes from 
the polarity of the solutions. Initial experiments done for different dilutions (1:20, 1:40, 
1:200, 1:1000) of magnetite (both samples) in methanol showed that the magnetite EPR 
spectra vary with the polarity of the environment; the more polar the environment is, the 
broader the peaks are. 
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Figure 2.5: EPR spectrum of dilutions of magnetite nanoparticles in methanol 
a) Fe3O4 with DEG and NMDEA on the surface; 
 b) Fe3O4 with DEG and DEA on the surface 
 
 
Fe3O4 
(DEG, 
NMDEA) 
in MeOH 
Xmin Xmax ∆B Beff ∆Blow ∆Bhigh A geff 
20X 1982.80 3675.27 1692.47 3060.21 1077.41 615.06 0.57 2.3 
40X 1956.99 3675.27 1718.28 2952.69 995.70 722.58 0.72 2.3 
200X 1993.55 4197.85 2204.30 3302.16 1308.61 895.69 0.68 2.1 
200X 2073.12 4260.22 2187.10 3236.72 1163.60 1023.50 0.88 2.8 
Fe3O4 
(DEG, 
DEA) in 
MeOH  
Xmin Xmax ∆B Beff ∆Blow ∆Bhigh A geff 
20X 2521.19 3747.26 1226.07 3067.54 546.35 679.72 1.24 2.3 
40X 2460.96 3654.76 1193.80 2994.41 533.45 660.35 1.24 2.4 
 
Table 2.2: Parameters of magnetite nanoparticles EPR spectra of  
dilutions of magnetite nanoparticles in methanol;  
a) Fe3O4 with DEG and NMDEA on the surface; 
 b) Fe3O4 with DEG and DEA on the surface 
 
The lineshapes of the SPR spectra of dilutions of magnetite nanoparticles in 
methanol sharpened asymptotically around 2 mg/mL magnetite nanoparticles. Below this 
concentration, the SPR lineshapes remained unchanged and the solutions were deemed 
magnetically dilute. 
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2.3.2 Characterization of citric acid-magnetite nanoparticles bioconjugates using 
EPR spectroscopy 
Solutions of the magnetite samples with DEG and NMDEA on the surface 
different concentrations of citric acid (0.25 mg/mL, 0.5 mg/mL, 1 mg/mL, 1.25 mg/mL, 
1.5 mg/mL) in the ratio 9:1, Fe3O4 to citric acid in methanol, were prepared and used for 
the investigation of the citrate ligand influence on the SPR spectra. Three hours after 
preparing the capillary tubes with the Fe3O4 nanoparticles in methanol and citric acid at 
all concentrations, the magnetite nanoparticles precipitated on the bottom of the tubes.  
The presence of the citric acid causes the precipitation of the magnetite nanoparticles in 
solution. Acquired SPR spectra of the citric acid-magnetite nanoparticles solutions and 
their calculated parameters are showed below. 
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Figure 2.6: EPR spectrum of citric acid-magnetite nanoparticles solutions 
 
Fe3O4-
citric acid 
in MeOH  
Xmin Xmax ∆B Beff ∆Blow ∆Bhigh A geff 
0.25mg/mL 2093.14 4252.74 2159.60 3147.13 1053.99 1105.61 1.05 2.24 
0.50mg/mL 2134.00 4276.41 2142.41 3254.68 1120.68 1021.73 0.91 2.16 
1.00mg/mL 2198.54 4388.26 2189.72 3349.32 1150.78 1038.94 0.90 2.11 
1.25mg/mL 2200.69 4383.96 2183.27 3338.57 1137.88 1045.39 0.92 2.11 
1.50mg/mL 2129.71 4280.71 2151.00 3280.49 1150.78 1000.22 0.87 2.15 
 
Table 2.3: Parameters of citric acid-magnetite nanoparticles EPR spectra 
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2.3.3 Characterization of salts-magnetite nanoparticles bioconjugates using EPR 
spectroscopy 
The surface of magnetite nanoparticles has Fe2+ and Fe3+ ions with incomplete 
coordination spheres. The presence of ligands such as carbonate and acetate can complete 
the coordination of these ions [38]. To test this hypothesis, solutions of Fe3O4 
nanoparticles with DEG and NMDEA on the surface in methanol (1 mg/mL) and acetate 
and respectively carbonate cosolutes (0.1 M) have been prepared and EPR signal of these 
salts-magnetite nanoparticles bioconjugates was collected (Figure 2.7).  
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Figure 2.7: EPR spectra of salts-magnetite nanoparticles bioconjugates  
(compared with the EPR spectrum of magnetite nanoparticles) 
a) Fe3O4 – acetic acid; b) Fe3O4 – potassium carbonate 
 
 
The geff ≈ 4 and geff ≈ 2 transitions undergo important changes in the presence of 
the acetate and carbonate salts. The geff ≈ 4 transition from distorted Fe3+ shifts to higher 
magnetic fields and/or merges with the geff ≈ 2 super-paramagnetic iron-oxide resonances. 
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2.3.4 Characterization of proteins-magnetite nanoparticles bioconjugates using 
EPR spectroscopy  
An alternative approach to complete the coordination of Fe2+ and Fe3+ ions on the 
surface of magnetite nanoparticles is to use proteins or polypeptides as ligands. The side-
chains of proteins and polypeptides have carboxylates and amino groups that are able to 
form covalent-coordinative bonds with the Fe2+ and Fe3+ ions on the surface of the 
magnetite nanoparticles [39]. Bovine serum albumin (BSA) was used in this study. 
Although, BSA is a well-known stabilizer of the nanoparticles [21], the experiments 
proved that the magnetite nanoparticles with DEG and NMDEA on the surface 
aggregated after the addition of BSA. The EPR signal acquired from the precipitated 
nanoparticles is shown below. 
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Figure 2.8: EPR spectrum of proteins (BSA)-magnetite nanoparticles bioconjugates  
(compared with the EPR spectrum of magnetite nanoparticles) 
 
The resulting lineshape of the proteins (BSA)-magnetite nanoparticles 
bioconjugates EPR spectrum is intermediate of the acetate, and respectively carbonate, 
magnetite nanoparticles bioconjugates. 
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2.3.5 Characterization of magnetite nanoparticles in methanol solutions using 
EPR spectroscopy as a function of temperature 
Both magnetite nanoparticles samples with DEG and NMDEA and respectively 
DEG and DEA on the surface, in methanol (2 mg/mL) were also studied by EPR at 
varying temperature. EPR data (Figures 2.9 and 2.10) were collected across a temperature 
range of 150-290 K and scaled to approximately the same peak intensity. The EPR 
signals of magnetite nanoparticles with DEG and NMDEA on the surface are 
dramatically different from the signals acquired from magnetite nanoparticles with DEG 
and DEA on the surface. The doublet at geff ≈ 3.59 for magnetite nanoparticles with DEG 
and NMDEA on the surface is characteristic of Fe3+ in two states, labeled Fe3+(I) and 
Fe3+(II) [40]. The calculated EPR parameters, the dependence of linewidth, ∆B, with the 
changes of temperature, and the effective g-factor, geff, dependence on the temperature are 
also showed below. 
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Figure  2.9: EPR spectra of magnetite nanoparticles in methanol  
as a function of temperature 
Fe3O4 with DEG and NMDEA on the surface; 
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Figure  2.10: EPR spectra of magnetite nanoparticles in methanol  
as a function of temperature 
 Fe3O4 with DEG and DEA on the surface 
 
 
Fe3O4 
(DEG, 
NMDEA)  
Xmin Xmax ∆B Beff ∆Blow ∆Bhigh A geff 
290 K 1787.09 3578.49 1791.40 1950.54 163.45 1627.95 9.96 3.45 
270 K 1759.14 3602.15 1843.01 1916.13 156.99 1686.02 10.73 3.51 
250 K 1722.58 3619.35 1896.77 1883.87 161.29 1735.48 10.76 3.57 
230 K 1690.32 3632.26 1941.94 1849.46 159.14 1782.80 11.20 3.63 
210 K 1655.91 3640.86 1984.95 1821.51 165.60 1819.35 10.98 3.69 
190 K 1634.41 3643.01 2008.60 1800.00 165.59 1843.01 11.13 3.74 
170 K 1615.05 3647.31 2032.26 1782.79 167.74 1864.52 11.11 3.77 
 150 K 1610.75 3673.12 2062.37 1795.69 184.94 1877.43 10.15 3.75 
Fe3O4 
(DEG, 
DEA)  
Xmin Xmax ∆B Beff ∆Blow ∆Bhigh A geff 
290 K 2292.47 3498.92 1206.45 2821.50 529.03 677.42 1.28 2.38 
270 K 2255.91 3455.91 1200.00 2774.19 518.28 681.72 1.32 2.42 
250 K 2212.90 3451.61 1238.71 2724.73 511.83 726.88 1.42 2.47 
230 K 2159.14 3384.95 1225.81 2675.27 516.13 709.68 1.37 2.51 
210 K 2023.66 3053.76 1030.10 2563.44 539.78 490.32 0.91 2.62  
190 K 2025.81 3043.01 1017.20 2561.29 535.48 481.72 0.90 2.63 
170 K 1913.98 2967.74 1053.76 2498.92 584.94 468.82 0.80 2.70 
 150 K 2255.92 4025.81 1769.89 3187.09 931.17 838.72 0.90 2.11 
 
Table 2.4: Parameters of magnetite nanoparticles EPR spectra  
as a function of temperature 
a) Fe3O4 with DEG and NMDEA on the surface; 
b) Fe3O4 with DEG and DEA on the surface 
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Figure 2.11: a) Linewidth, ∆B, dependence on the temperature; 
 b) Effective g-factor, geff, dependence on the temperature 
1) Fe3O4 with DEG and NMDEA on the surface;  
2) Fe3O4 with DEG and DEA on the surface 
 
As the temperature decreases, there is a linear increase of the geff; below 170 K, 
the geff begins to decrease. The broad linewidth of the geff ≈ 2 transition is characteristic of 
the superparamagnetic behavior of iron oxide compounds. The linewidth increases 
linearly as the temperature decreases and it displays the same deviations from linearity as 
geff. 
2.3.6 Discussion 
Although, TEM images show no differences between the two prepared magnetite 
nanoparticles samples (with DEG and NMDEA on the surface, and respectively, with 
DEG and DEA on the surface) [35], SPR spectra of these two samples look significantly 
different. For both samples, at concentrations below 2 mg/mL, dipolar exchange effects 
are minimal and magnetically dilute samples are obtained. The EPR signal became 
broader with the decrease of the magnetite concentration due to the changes in the 
interparticle interactions, so in spin-spin interactions. 
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Between 0.25 mg/mL and 0.5 mg/mL citric acid in methanol, saturation of the 
magnetite nanoparticles occurs. Citric acid is bound to the magnetite nanoparticles 
surface by a coordinative-covalent bond and it causes their precipitation at all 
concentrations. It is believed that citric acid changes the coating of the nanoparticles and 
causes agglomeration of the nanoparticles in solution [38]. Precipitation can also be caused 
by the destabilization of the magnetite electrostatic shell, similar to gold nanoparticle 
electrostatic shell (Figure 2.12). Although, this effect would produce the broadening of 
the EPR lines, the linewidth values for citric acid coated and uncoated magnetite 
nanoparticles are similar. 
 
 
 
 
 
 
 
Figure 2.12: Magnetite nanoparticles electrostatic shell 
 
EPR characterization of magnetite nanoparticles and different cosolutes solutions 
showed that precipitation of the nanoparticles occurs in the presence of cosolutes. The 
changes in the EPR spectra of magnetite nanoparticles with acetate and carbonate may be 
the result of the modification of the nanoparticles outer layer by these cosolutes (it is 
postulated that the outer layer of the magnetite nanoparticles with lower symmetry 
comparing to the interior gives the EPR spectrum [41]). At the surface of the nanoparticle 
 
30  
  
the coordination state of Fe3+/Fe2+ ions is incomplete, so departures from axially 
symmetric states can occur. In the presence of ligands like acetate and carbonate salts, or 
proteins like BSA, these defects become minimal due to the binding that establish. The 
ligands bounded to the surface of the magnetite nanoparticles change the coordination 
environment of the Fe3+/Fe2+ ions and they are responsible for the re-achievement of the 
axial symmetry of the Fe3+ ions. As a result of ligands linkage on the surface of the 
nanoparticles, the ferromagnetic behavior of the magnetite is altered.  
geff  and linewidths of the EPR spectra increase linearly with the decrease of the 
temperature for both magnetite nanoparticles samples. Also, at lower temperatures, the 
system being more ordered, there is less Brownian movement of the nanoparticles and the 
interactions are minimal, so the signal intensity decreases. As a consequence, the EPR 
line broadens and there is a shift of the signal down to lower fields. The linewidth values 
are almost linearly temperature dependent (Figure 2.11); as the temperature decreased, 
the linewidths increased, however, deviations from linearity begin to occur at 170 K.  
The ferromagnetic transition takes place in magnetite at room temperature. At low 
temperature, the electron cannot move between Fe3+ and Fe2+ ions, this temperature being 
known as Verwey transition [42]. Below 125 K (the Verwey transition temperature, Tv), a 
change in the magnetite crystal structure also occurs. Above Tv, magnetite is cubic with a 
Fe2.5+ charge resulting from the exchange between the two iron ions in octrahedral sites 
(Fe3+ and Fe2+), while below Tv, magnetite has a monoclinic crystal structure with fixed 
charges. The geff and linewidths deviations from the linearity with temperature could 
reflect magnetite’s impending Verwey transition. The phase transition from cubic to 
monoclinic is also responsible for these changes in the EPR spectra [43]. 
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Single crystals of magnetite are known for having geff ≈ 2 when the applied field is 
aligned with the nanoparticles easy axes. Due to the Brownian motion in the solution, in 
reality most of the nanoparticles easy axes are slightly differently oriented comparing to 
the direction of the applied magnetic field, so broad EPR signals and high geff values are 
obtained. With decreasing temperature, the probability of the nanoparticles to align their 
easy axis with the magnetic field is even lower, so more nanoparticles will be oriented off 
the direction of the magnetic field and this effect produces even a broader EPR signal [44]. 
At higher temperatures, Brownian motion favors the alignment of the nanoparticles easy 
axes with the applied magnetic field and a sharp EPR signal is obtained. 
 
2.4 Conclusions 
In summary, the initial hypothesis that ligands on the surface of the magnetite 
nanoparticles induce modifications in the characteristics of the SRP spectra was 
demonstrated. From the experiments it was concluded that the EPR signal is sensitive to 
the changes in the interparticle dipolar interaction upon dilutions. The geff ≈ 4 transition 
from distorted Fe3+ is shifted to higher magnetic fields and the linewidths are increased 
by coatings on the surface of magnetite nanoparticles. EPR spectra of the magnetite 
nanoparticles are strongly dependent of temperature. The observed temperature 
dependence of the geff and linewidths is accounted for by the averaged thermal 
fluctuations of the magnetocrystalline anisotropy energy. Changes in the EPR spectra of 
the magnetite nanoparticles with ligands immobilized on the surface of the particles are 
an indication that these biomagnetic systems can be used further as sensors for detecting 
the conformational changes in a protein. 
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